Back

Comparison between oral procainamide and mexiletine for the treatment of recurrent and refractory ventricular tachyarrhythmias.

3 April 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Moderated ePosters - Variety on how to improve treatment of arrhythmias Antiarrhythmic Drug Treatment EHRA Premium Access EHRA 2022

About the speaker

Photo
Doctor Mauro Toniolo

Hospital Santa Maria della Misericordia, Udine (Italy)

7 More presentations in this session

Presentation thumbnail
Is it possible to predict mortality and recurrence of VT afterablation? PAINESD risk score applicability vs new predictors
Doctor J. Brito (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Effectiveness and safety of bipolar ablation of heart arrhythmia. A systematic review with meta-analysis.
Doctor M. Farkowski (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Quantifying the variability of bipolar voltage amplitude with sensing angle in residual conduction isthmuses in atrial scar
Doctor M. Martinez Cossiani (Madrid, ES)
Abstract Slides
Presentation thumbnail
Validation of the peak frequency of bipolar electrograms for detection of residual conduction in atrial scar tissue
Doctor M. Martinez Cossiani (Madrid, ES)
Abstract Slides
Presentation thumbnail
Acute procedural characteristics, efficacy, and safety of a novel cryoballoon for the treatment of paroxysmal atrial fibrillation: Results from the POLAR-ICE study
Doctor S. Yap (Rotterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
Moderated ePosters - Variety on how to improve treatment of arrhythmias

The Event

Event poster

EHRA 2022

3 April - 5 April 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources